Bioventix PLC (AIM:BVXP)

Bioventix Cash Flow Statement

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	7.85	8.1	8.37	7.67	6.73	7.2
Depreciation & Amortization	0.11	0.11	0.13	0.14	0.14	0.13
Loss (Gain) From Sale of Assets	-	-	-	0.02	-0	0
Loss (Gain) From Sale of Investments	0.18	0.18	-	-	-	-
Stock-Based Compensation	0.09	0.09	0.17	0.24	0.26	0.12
Other Operating Activities	-0.36	0.22	-0.09	0.13	0.22	-0.18
Change in Accounts Receivable	-0.52	-0.39	-0.63	-0.6	-0.98	0.28
Change in Inventory	0.03	-0.05	-0.1	-0.13	-0.09	-0.01
Change in Accounts Payable	0.15	0.08	-0.05	0.08	0.06	0.13
Operating Cash Flow	7.54	8.34	7.8	7.56	6.34	7.68
Operating Cash Flow Growth	-5.71%	6.94%	3.25%	19.25%	-17.51%	30.72%
Capital Expenditures	-0.03	-0.02	-0.01	-0.01	-0.26	-0.34
Sale of Property, Plant & Equipment	-	-	-	-	0	-
Investment in Securities	-	-	-	-	-	-0.22
Other Investing Activities	0.22	0.2	0.1	0	0.03	0.04
Investing Cash Flow	0.19	0.19	0.09	-0.01	-0.23	-0.52
Issuance of Common Stock	-	-	0.14	-	0.02	0.88
Common Dividends Paid	-8.09	-8.25	-8.44	-7.92	-7.71	-6.5
Other Financing Activities	-	-	-	-0	-	-
Financing Cash Flow	-8.09	-8.25	-8.3	-7.92	-7.69	-5.62
Net Cash Flow	-0.36	0.28	-0.41	-0.37	-1.58	1.54
Free Cash Flow	7.51	8.33	7.79	7.55	6.08	7.34
Free Cash Flow Growth	-6.02%	6.88%	3.27%	24.16%	-17.24%	26.76%
Free Cash Flow Margin	54.97%	61.21%	60.80%	64.38%	55.60%	71.20%
Free Cash Flow Per Share	1.42	1.57	1.47	1.44	1.16	1.41
Cash Interest Paid	-	-	-	0	-	-
Cash Income Tax Paid	2.56	2.08	1.75	1.47	1.14	1.16
Levered Free Cash Flow	6.26	6.91	5.84	5.63	4.59	5.15
Unlevered Free Cash Flow	6.26	6.91	5.84	5.63	4.59	5.15
Change in Net Working Capital	0.46	-0.08	0.75	0.48	0.78	-0.25

Updated Nov 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.